MedTrace Logo

To Evaluate the Efficacy and Safety of "Rongyang Zhengyifang" Tea Bag With COVID-19 Variant Virus

NCT05504447 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2023-08-03

No results posted yet for this study

Summary

The strategy of our study is to use traditional Chinese medicine tea to regulate physical fitness and strength can be enhanced to help patients with mildly diagnosed COVID-19 variant virus to achieve self-recovery ability and avoid the development of moderate and severe symptoms.

Conditions

  • Herbal Interaction

Interventions

OTHER

Rong-Yang Zhengyifang" tea bag

One tea bag is 4 grams, 3 bags per day, for a total of 7 days

OTHER

placebo tea bag

One tea bag is 4 grams, 3 bags per day, for a total of 7 days

Sponsors & Collaborators

  • Taipei Veterans General Hospital, Taiwan

    lead OTHER_GOV

Principal Investigators

  • Yen-Ying Kung, doctor · TaipeiVGH Center for Traditional Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-15
Primary Completion
2023-02-28
Completion
2024-06-01

Countries

  • Taiwan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05504447 on ClinicalTrials.gov